AWM
FLNA

Accurate Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Accurate Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-75
Closed -$2.34K – 1190
2022
Q4 		$2.34K Buy
+75
New +$2.7K ﹤0.01% 1172

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Accurate Wealth Management's FLNA Position: Q1 2023 in Review

Accurate Wealth Management sold out of Filana Therapeutics (FLNA) in Q1 2023, closing a stake of 75 shares — an estimated $2.34K sold.

Accurate Wealth Management first reported a position in FLNA in Q4 2022 and held it in 1 quarter. The position peaked at $2.34K in Q4 2022. 145 funds tracked by Wall St. Rank hold FLNA as of Q1 2023.

  • Accurate Wealth Management reported no remaining Filana Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Accurate Wealth Management sold 75 Filana Therapeutics shares in Q1 2023, an estimated $2.34K.
  • Accurate Wealth Management first reported a position in Filana Therapeutics in Q4 2022 and held it in 1 quarter.
  • Accurate Wealth Management's Filana Therapeutics position peaked at $2.34K in Q4 2022.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.